Name: “Advances in CAR-T Therapy Targeting Lymphomas”
Start: 2021-12-09T12:00:00-08:00
End: 2021-12-09T13:00:00-08:00

About this Event

Virtual Event View stream information

Add to calendar

Part of the USC/CHLA Cell Therapy Program Seminar Series

**For USC/CHLA participants**

Speaker:

Raghuveer Ranganathan, MD
Assistant Professor of Clinical Medicine
Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases
USC Norris Comprehensive Cancer Center

Learn more about:

CD19-targeting CAR-T causes B-cell aplasia and hypogammaglobulinemia, which significantly hamper patients’ immune systems with increased infection risk long-term
How targeting surface immunoglobulin to preserve non-Hodgkin lymphoma patients’ humoral immunity and lessening their infection risk
Targeting CD30 with CAR-T in relapsed/refractory Hodgkin lymphoma in a Phase I/II trial that led to high rate of durable clinical responses with an excellent safety profile

Join us and actively participate in the discussion!

This program is open to all eligible individuals. USC operates all of its programs and activities consistent with the university’s Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation or any other prohibited factor.

“Advances in CAR-T Therapy Targeting Lymphomas”

Event Details

See Who Is Interested

Dial-In Information